ES
26
14
HP
34
-10
RRC
58
6
WY
36
5
GWW
48
-2
HUM
29
4
PEG
55
2
GOOG
79
2
EBAY
39
-3
SLB
44
3
TAP
54
-3
UNH
44
2
CHRW
51
-2
EXR
31
-11
PAYX
39
3
LLY
45
8
VRTX
47
2
ISRG
66
2
CPB
22
-2
URBN
75
8
ES
26
14
HP
34
-10
RRC
58
6
WY
36
5
GWW
48
-2
HUM
29
4
PEG
55
2
GOOG
79
2
EBAY
39
-3
SLB
44
3
TAP
54
-3
UNH
44
2
CHRW
51
-2
EXR
31
-11
PAYX
39
3
LLY
45
8
VRTX
47
2
ISRG
66
2
CPB
22
-2
URBN
75
8
Financhill
Back

Virtus Investment Partners Vs. Verona Pharma PLC Industry Stock Comparison

Buy
56

VRTS
Virtus Investment Partners

Last Price:
$222.64
Seasonality Move:
2.04%
Sell
48

VRNA
Verona Pharma PLC

Last Price:
$45.02
Seasonality Move:
1.28%
Buy
56
Virtus Investment Partners (VRTS) is a Buy

Is Virtus Investment Partners a Buy, Sell or Hold?

  • The current Virtus Investment Partners [VRTS] share price is $220.38. The Score for VRTS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • VRTS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Verona Pharma PLC (VRNA) is a Sell

Is Verona Pharma PLC a Buy, Sell or Hold?

  • The current Verona Pharma PLC [VRNA] share price is $45.28. The Score for VRNA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VRNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRTS Stock Price Chart

What is Virtus Investment Partners's stock price today?

  • The Virtus Investment Partners share price today is $220.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTS is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRNA Stock Price Chart

What is Verona Pharma PLC's stock price today?

  • The Verona Pharma PLC share price today is $45.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRTS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.22 Sell
Relative Strength Index (14 RSI): 33.37 Sell
Chaikin Money Flow: 30698 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (229.52 - 248.88) Sell
Bollinger Bands (100): (201.46 - 235.02) Buy

VRNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.47 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 672029 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.1 - 41.82) Buy
Bollinger Bands (100): (26.7 - 38.58) Buy

VRTS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 229.27 Sell
20-day SMA: 239.79 Sell
50-day SMA: 231.8 Sell
200-day SMA: 224.5 Sell
8-day EMA: 227.61 Sell
20-day EMA: 234.04 Sell
50-day EMA: 231.2 Sell
200-day EMA: 222.85 Sell

VRNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.71 Buy
20-day SMA: 40.52 Buy
50-day SMA: 37.79 Buy
200-day SMA: 24.36 Buy
8-day EMA: 42.01 Buy
20-day EMA: 40.56 Buy
50-day EMA: 37.61 Buy
200-day EMA: 27.82 Buy

Virtus Investment Partners Earnings Growth & VRTS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.66 per share, and an increase next year of $3.49 per share.

Verona Pharma PLC Earnings Growth & VRNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.40 per share.

Virtus Investment Partners Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Verona Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):